Cure My Disease

Don't miss your cure!

 Log in / Sign up

New registry tracks PRRT outcomes for neuroendocrine cancer patients

NCT ID NCT04090034

Recruiting now Disease control Sponsor: Methodist Health System Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is tracking 50 adults with neuroendocrine tumors who are receiving peptide receptor radionuclide therapy (PRRT). Researchers are collecting data on patient characteristics, treatment responses, survival, and side effects. The goal is to better understand who benefits from PRRT and how the therapy affects the disease over time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Peptide receptor radionuclide therapy (PRRT)
What this could lead to
If successful, this could help doctors better understand which patients benefit most from PRRT and improve treatment decisions for neuroendocrine tumors.
What could go wrong
This is an observational registry, not a controlled trial, so it cannot prove PRRT works. Results may be limited by small size and lack of a comparison group.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

digestive system neuroendocrine neoplasm digestive system neuroendocrine tumor, grade 1/2 neuroendocrine neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR NEUROENDOCRINE TUMORS

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • Clinical Research Institute at Methodist Health System

    RECRUITING

    Dallas, Texas, 75203, United States

  • Methodist Dallas Medical Center

    ENROLLING_BY_INVITATION

    Dallas, Texas, 75203, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.